Ignite Creation Date:
2024-05-05 @ 6:40 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00522990
Status:
TERMINATED
Last Update Posted:
2016-02-05
First Post:
2007-08-29
Brief Title:
Study to Assess the Safety of Escalating Doses of AT9283 in Patients With Leukemias
Sponsor:
Astex Pharmaceuticals Inc
Organization:
Astex Pharmaceuticals Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-09
Start Date Type:
None
Primary Completion Date:
2009-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-04
Completion Date Type:
ACTUAL
First Submit Date:
2007-08-29
First Submit QC Date:
August 29 2007
Study First Post Date:
2007-08-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2016-01-08
Disp First Submit QC Date:
January 8 2016
Disp First Post Date:
2016-02-05
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2024-08-01
Last Update Post Date:
2016-02-05
Last Update Post Date Type:
ESTIMATED